Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported DNA-repair gene defects to assess biomarker eligibility for niraparib interventional studies.
Inclusion Criteria:
Long Beach, California 90806, United States
Fort Lauderdale, Florida 33308-4668, United States
Miami, Florida 33176, United States
Frederick, Maryland 21702-4337, United States
Plymouth, Massachusetts 02360, United States
Bala-Cynwyd, Pennsylvania 19004, United States
Horsham, Pennsylvania 19044, United States
Caba, C1027AAP, Argentina
Ciudad Automoma Buenos Aires, C1120AAT, Argentina
Ciudad Autonoma de, C1199ABB, Argentina
Ciudad de Buenos Aires, C1430EGF, Argentina
Córdoba, 5000, Argentina
Macquarie University, 2109, Australia
Haine-Saint-Paul, La Louviere, 7100, Belgium
Brasília, 7020-730, Brazil
Goiânia, 74605-070, Brazil
Joinville, 89201-260, Brazil
Rio de Janeiro, 22775-001, Brazil
São Paulo, 01246-000, Brazil
Kingston, Ontario K7L 3N6, Canada
Québec, Quebec G1R2J6, Canada
Zrifin, 60930, Israel
Lodz, 93-513, Poland
Warsaw, 02-781, Poland
Parla, Madrid, 28981, Spain
Puerto Real, Cádiz, 11510, Spain
Istanbul, 34098, Turkey (Türkiye)
Istanbul, 34722, Turkey (Türkiye)
Cherkasy, 18009, Ukraine
Dnipo, 49005, Ukraine
Dnipro, 49100, Ukraine
Kamyanske, 51900, Ukraine
Khakhiv, 61070, Ukraine
Kharkiv, 61037, Ukraine
Khmelnytsky, 29000, Ukraine
Kropyvnytskyi, 25011, Ukraine
Kyiv, 03115, Ukraine
Poltava, 36024, Ukraine
Zhytomyr, 10002, Ukraine